SeaStar Medical Holding Corp (ICUCW) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
3513 BRIGHTON BLVD DENVER, CO 80216 |
| State of Incorp. | CO |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 1,819 | 176 | 47 | 52 | |||
| Cash and cash equivalent | 1,819 | 176 | 47 | 52 | |||
| Receivables | 112 | 12 | |||||
| Inventory, net of allowances, customer advances and progress billings | |||||||
| Inventory | |||||||
| Prepaid expense | 1,835 | 2,132 | 2,977 | 15 | |||
| Deferred costs | 3,623 | ||||||
| Total current assets: | 3,766 | 2,308 | 3,036 | 3,689 | |||
| Noncurrent Assets | |||||||
| Asset, held-in-trust | 105,582 | ||||||
| Other noncurrent assets | |||||||
| Other undisclosed noncurrent assets | 892 | 1,205 | 1,731 | ||||
| Total noncurrent assets: | 892 | 1,205 | 1,731 | 105,582 | |||
| Other undisclosed assets | (3,336) | ||||||
| TOTAL ASSETS: | 4,658 | 3,513 | 4,767 | 105,934 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities, including: | 6,234 | 5,895 | 4,172 | 377 | |||
| Accounts payable | 3,046 | 4,372 | 1,927 | ||||
| Accrued liabilities | 3,188 | 1,523 | 2,245 | ||||
| Other undisclosed accounts payable and accrued liabilities | 377 | ||||||
| Debt | 574 | 565 | 1,178 | ||||
| Derivative instruments and hedges, liabilities | |||||||
| Other undisclosed current liabilities | 33 | 6,586 | |||||
| Total current liabilities: | 6,841 | 13,046 | 5,350 | 377 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 4,337 | 7,652 | |||||
| Long-term debt, excluding current maturities | 4,337 | 7,652 | |||||
| Other undisclosed noncurrent liabilities | 10,553 | ||||||
| Total noncurrent liabilities: | 4,337 | 7,652 | 10,553 | ||||
| Total liabilities: | 6,841 | 17,383 | 13,002 | 10,930 | |||
| Equity | |||||||
| Equity, attributable to parent, including: | (2,183) | (13,870) | (8,235) | (10,566) | |||
| Common stock | 2 | 5 | |||||
| Additional paid in capital | 137,379 | 100,859 | 91,089 | ||||
| Accumulated deficit | (139,564) | (114,734) | (99,325) | (10,566) | |||
| Other undisclosed equity, attributable to parent | 1 | 0 | |||||
| Other undisclosed equity | 105,570 | ||||||
| Total equity: | (2,183) | (13,870) | (8,235) | 95,004 | |||
| TOTAL LIABILITIES AND EQUITY: | 4,658 | 3,513 | 4,767 | 105,934 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|---|
| Revenues | 135 | 151 | 12 | |||
| Net investment income | 12 | |||||
| Other income | 151 | |||||
| Cost of revenue (Cost of Product and Service Sold) | ||||||
| Gross profit: | 135 | 151 | 12 | |||
| Operating expenses | (17,977) | (14,210) | (11,609) | (1,122) | ||
| Other undisclosed operating loss | (151) | (12) | ||||
| Operating loss: | (17,842) | (14,210) | (11,609) | (1,122) | ||
| Nonoperating income (expense) | (6,985) | (12,022) | (11,403) | 12 | ||
| Investment income, nonoperating | 12 | |||||
| Other nonoperating income (expense) | (6,985) | (12,022) | (11,403) | |||
| Interest and debt expense | (4,949) | (630) | ||||
| Loss from continuing operations before equity method investments, income taxes: | (24,827) | (31,181) | (23,642) | (1,111) | ||
| Other undisclosed income from continuing operations before income taxes | 4,949 | 630 | ||||
| Loss from continuing operations before income taxes: | (24,827) | (26,232) | (23,012) | (1,111) | ||
| Income tax expense | (3) | (1) | ||||
| Loss from continuing operations: | (24,830) | (26,232) | (23,013) | (1,111) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (1,111) | |
| Other undisclosed net income | 1,186 | |||||
| Net income (loss) available to common stockholders, diluted: | (24,830) | (26,232) | (23,013) | 75 | ||
Comprehensive Income ($ in thousands)
| 9/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | (24,830) | (26,232) | (23,013) | 75 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (24,830) | (26,232) | (23,013) | 75 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.